A Safety and Efficacy Study of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects Participating in an Intensive Behavior Modification Program

Clinical trial NCT00456521 · COMPLETED

Trial details

NCT number: NCT00456521
Sponsor: Orexigen Therapeutics, Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Obesity Overweight

Start date: 2007-03-01
Primary completion: 2008-12-01
Enrollment: 793

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.